Related Experiment Video
Updated: Jun 16, 2026

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
Published on: August 28, 2012
Reversing the Fold: Polyanionic Macrocycle Dissolves αA66-80 Crystallin Peptide Aggregates
Frank Boateng Osei1, Yuvraj Dangat2, Roi Yasay1
1Department of Chemistry, Oakland University, 146 Library Drive, Rochester, Michigan 48309-4479, United States.
A novel compound, MR-8S, effectively breaks down protein aggregates linked to cataract formation. This resorcinarene derivative shows significant deaggregation capabilities, offering potential for new anticataract drug development.
Area of Science:
- Biochemistry
- Materials Science
- Ophthalmology
Background:
- Cataract is a primary cause of global blindness with no effective pharmacological treatments.
- Protein aggregation, specifically of alphaA-Crystallin peptide (αA66-80), is implicated in cataract pathogenesis.
- Existing treatments primarily involve surgical intervention.
Purpose of the Study:
- To synthesize and evaluate the efficacy of octa-sulfonated polyanionic resorcinarene (MR-8S) in inhibiting and deaggregating αA66-80-Crystallin peptide aggregates.
- To investigate the interaction mechanisms between MR-8S and the αA66-80-Crystallin peptide.
- To assess MR-8S as a potential therapeutic scaffold for anticataract drug development.
Main Methods:
- Synthesis of octa-sulfonated polyanionic resorcinarene (MR-8S).
- Nuclear Magnetic Resonance (NMR) and Isothermal Titration Calorimetry (ITC) to study molecular interactions.
- Fluorescence aggregation assays, Dynamic Light Scattering (DLS), and Transmission Electron Microscopy (TEM) for deaggregation studies.
- Molecular Dynamics (MD) simulations to elucidate aggregation mechanisms.
Main Results:
- MR-8S demonstrated strong binding interactions with the αA66-80-Crystallin peptide, with dissociation constants ranging from 1 nM to 1000 μM.
- MR-8S exhibited concentration-dependent deaggregation of αA66-80-Crystallin peptide aggregates, significantly reducing particle size.
- MR-8S showed superior deaggregation efficacy compared to previously reported macrocycles and other polyionic resorcinarenes, with a lower effective concentration (44 ± 1 μM) to break down 50% of aggregates.
- MD simulations indicated that MR-8S shields hydrophobic residues, preventing peptide aggregation.
Conclusions:
- MR-8S effectively inhibits and deaggregates αA66-80-Crystallin peptide aggregates, addressing a key mechanism in cataract formation.
- The strong binding affinity and deaggregation capabilities of MR-8S highlight its potential as a therapeutic agent.
- MR-8S represents a promising molecular scaffold for the development of novel anticataract pharmacological treatments.
More Related Videos
06:34A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation
Published on: March 27, 2017
06:27Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Folding
Clot Retraction and Fibrinolysis
Pinching-off of Coated Vesicles